ANALYSIS OF RET-HE IN CHRONIC KIDNEY DISEASE PATIENTS AT DR.WAHIDIN SUDIROHUSODO HOSPITAL, MAKASSAR
DOI:
https://doi.org/10.24293/ijcpml.v25i1.1481Keywords:
Reticulocyte hemoglobin equivalent, Fe, transferrin saturation, chronic kidney disease, iron deficiencyAbstract
Anemia, the common feature of Chronic Kidney Disease (CKD), is a multifactorial process due to disordered erythropoiesis and iron homeostasis. Determining the cause of anemia is important for adequate management. A bone marrow biopsy using Prussian Blue as the gold standard for diagnosis is invasive and more complicated to perform. Reticulocytes-Hemoglobin (Ret-He) a new parameter that indicates the hemoglobin content in reticulocytes is faster, easier, and less expensive. This study aimed to analyze the Ret-He in determining the iron status in patients with CKD. A cross-sectional study was held in the Clinical Pathology Laboratory of Dr. Wahidin Sudirohusodo Hospital Makassar during April-August 2016. Forty-five (45) samples were tested for iron serum (Fe), Total Iron Binding Capacity (TIBC), and Complete Blood Count (CBC) ordered by the physician. Reticulocytes-Hemoglobin was tested using the whole blood. Subjects were around the age of 19-71 years, no significant difference was found between numbers of males and females (46.6% and 53.3%). Hemoglobin median was 8 (5.0-15) g/dL, Fe 50 (6-177) U/mL, TIBC 183 (73-379), Transferrin Saturation (Tsat) 25 (5-95)%. Spearman correlation test method showed significant correlations between Ret-He and iron serum r=0.533, p <0.001, Ret-He and TIBC r=0.321 p=0.031 Ret-He and transferrin saturation r=0.416 p=0.019. The Mann-Whitney method showed no significant difference of Ret-He in both groups (Tsat <20% and >20%). There were significant correlations between Ret-He and iron, Ret-He and TIBC, Ret-He and transferrin saturation. A further study using larger samples is suggested to consider factors affecting the result of Ret-He.
Downloads
References
Urrechaga E, Borque L, Escanero JF. Assessing iron status in CKD patients: New laboratory parameters. [cited at January 10, 2016]. Available at: http://www.Intechopen.com
Lankhorst CE, Wish JB. Anemia in renal disease: Diagnosis and management, blood reviews. Blood Review, 2010; 24(1): 39-47.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med, 2005; 352(10): 1011-23.
Sysmex America White Paper. Reticulocyte hemoglobin content (Ret-He): A parameter with well-established clinical value. [cited at January 21, 2016]. Available at: http://www.sysmex.com
Schapkaitz E, Buldeo S, Mahlangu JN. Diagnosis of iron deficiency anemia in hospital patients: Use of the reticulocyte hemoglobin content to differentiate iron deficiency anemia from anemia of chronic disease. S Afr Med J, 2016; 106(1): 53-4.
Dalimunthe NN, Lubis AR. Usefulness of reticulocyte hemoglobin equivalent in management of regular hemodialysis patients with iron deficiency anemia. Rom J Intern Med, 2016; 54(1): 31– 6.
Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret-He) and assessment of iron-deficient states. Clin Lab Haem, 2006; 28(5): 303-8.
Bargman JM, Skorecki K. Chronic kidney disease. In: Jameson JL, et al. Editors. Harrison's: Nephrology and acid-base disorders. 17th Ed., Chicago, McGraw-Hill, 2010; 113-5.
PERNEFRI (Indonesian Society of Nephrology and Hypertension). Konsensus manjemen anemia pada penyakit ginjal kronik (Consensus on management of anemia in chronic kidney disease), Jakarta, PERNEFRI, 2011; 3-15.
Babitt JL, Lin HY. Mechanism of anemia in CKD. J Am Soc Nephrol, 2012; 23(10): 1632-33.
Kidney disease: Improving global outcomes (KDIGO) anemia workgroup. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney inter., 2012; 2: 279-335.
Vali DV, Moeis SE, Rotty LW. Gambaran anemia pada penderita penyakit ginjal kronik di BLU RSUP Dr. R.D. Kandou.[cited on January 21, 2016]. Available at: https://ejournal.unsrat.ac.id/index.php/eclinic/article/view/3282
Andrews NC. Iron deficiency and related disorders. In: Greer PJ, et al. Editors: Wintrobe's clinical hematology. 12th Ed., Philadelphia, Lippincott Williams & Wilkins, 2009; 811-30.
Miwa N, Akiba T, KimataT, Hamaguchi Y, Arakawa Y, et al. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of hemodialysis patients with iron deficiency. Int Jnl Lab Hem. 2010; 32(2): 248-55.
Wish JB. Assessing iron status; Beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006; 1: S4-8.
Hori WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol. 2007; 108382-93.
Canals C, Remacha AF, Sarda MP, Royo MT, Romero MA. Clinical utility of the new Sysmex XE 2100 parameter-reticulocyte hemoglobin equivalent in the diagnosis of anemia. Hem J. 2005; 90: 1133-1134.
